US2013184306A1PendingUtilityA1
Pyrido[3,4-b]indoles and methods of use
Assignee: MEDIVATION TECHNOLOGIES INCPriority: Mar 24, 2008Filed: Mar 8, 2013Published: Jul 18, 2013
Est. expiryMar 24, 2028(~1.7 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 37/08A61P 37/00A61P 25/00A61P 3/14A61P 25/18A61P 25/28A61P 25/16A61P 25/22A61P 25/24C07D 471/14C07D 471/04
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A compound of formula (E):
or a salt thereof,
wherein:
R 1 is H, hydroxyl, nitro, cyano, halo, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, perhaloalkyl, acyl, acyloxy, carbonylalkoxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aralkyl, C 1 -C 8 perhaloalkoxy, alkoxy, aryloxy, carboxyl, thiol, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl or carbonylalkylenealkoxy;
each R 2a and R 2b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, cyano, hydroxyl, alkoxy or nitro, or R 2a and R 2b are taken together with the carbon to which they are attached to form a cycloalkyl moiety or a carbonyl moiety;
each R 3a and R 3b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, cyano, nitro, hydroxyl, alkoxy, amino, substituted amino, cycloalkyl, acylamino or acyloxy or R 3a and R 3b are taken together with the carbon to which they are attached to form a cycloalkyl moiety or a carbonyl moiety;
X 7 , X 8 and X 10 are each CR 4 and X 9 is N; or X 7 and X 10 are each N, and X 8 and X 9 are each CR 4 ;
m and q are independently 0 or 1;
n is 1 or 0, provided that n is 0 only when Q is a substituted heterocycle wherein the substituted heterocycle is a lactam;
each R 4 is independently H, hydroxyl, nitro, cyano, halo, C 1 -C 8 perhaloalkyl, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C 1 -C 8 perhaloalkoxy, C 1 -C 8 alkoxy, aryloxy, carboxyl, thiol, carbonylalkoxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, carbonylalkylenealkoxy, alkylsulfonylamino or acyl;
each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is independently H, hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy, is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a cycloalkyl moiety or a carbonyl moiety, is taken together with a geminal R 8(a-f) to form a methylene or a substituted methylene, is taken together with a vicinal R 8(a-f) and the carbon atoms to which they are attached to form a substituted or unsubstituted C 3-8 cycloalkyl, substituted or unsubstituted C 3-8 cycloalkenyl or substituted or unsubstituted heterocyclyl moiety or is taken together with a vicinal R 8(a-f) to form a bond, provided that when an R 8(a-f) is taken together with a vicinal R 8 to form a bond, the geminal R 8(a-f) is other than hydroxyl;
each R 10a and R 10b is independently H, halo, a substituted or unsubstituted C 1 -C 8 alkyl, hydroxyl, alkoxyl, cyano or nitro, or R 10a and R 10b are taken together with the carbon to which they are attached to form a cycloalkyl moiety or a carbonyl moiety; and
Q is a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or a unsubstituted heterocyclyl, unsubstituted amino, substituted amino, alkoxy, aminoacyl, acyloxy, carbonylalkoxy, aminocarbonylalkoxy, acylamino, carboxy, cyano or alkynyl.
26 . The compound of claim 25 , or a salt thereof, wherein X 7 , X 8 and X 10 are each CR 4 and X 9 is N.
27 . The compound of claim 25 , or a salt thereof, wherein X 7 and X 10 are each N, and X 8 and X 9 are each CR 4 .
28 . The compound of claim 25 , or a salt thereof, wherein X 7 , X 8 , X 9 and X 10 are taken together to provide an aromatic moiety selected from the group consisting of:
29 . The compound of claim 25 , or a salt thereof, wherein each R 4 is independently H, hydroxyl, halo, C 1 -C 8 perhaloalkyl, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C 1 -C 8 perhaloalkoxy, C 1 -C 8 alkoxy, aryloxy, carboxyl, thiol, carbonylalkoxy, thioalkyl, alkylsulfonylamino or acyl.
30 . The compound of claim 25 , or a salt thereof, wherein each R 4 is independently nitro, cyano, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, or carbonylalkylenealkoxy;
31 . The compound of claim 25 , or a salt thereof, wherein each R 4 is independently H, halo. substituted or unsubstituted C 1 -C 8 alkyl, or C 1 -C 8 perhaloalkyl.
32 . The compound of claim 25 , or a salt thereof, wherein each R 4 is independently methyl, CF 3 , CH 2 F, CHF 2 , chloro or fluoro.
33 . The compound of claim 28 , or a salt thereof, wherein the compound contains at least one R 4 and wherein each R 4 is independently halo, substituted or unsubstituted C 1 -C 8 alkyl, or perhaloalkyl.
34 . The compound of claim 28 , or a salt thereof, wherein the compound contains at least one R 4 and wherein each R 4 is methyl, CH 2 F, CHF 2 , CF 3 , chloro or fluoro.
35 . The compound of claim 25 , or a salt thereof, wherein q is 0, and m is 1.
36 . The compound of claim 25 , or a salt thereof, wherein R 1 is substituted or unsubstituted C 1 -C 8 alkyl.
37 . The compound of claim 36 , or a salt thereof, wherein R 1 is methyl.
38 . The compound of claim 25 , or a salt thereof, wherein each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, or halo.
39 . The compound of claim 25 , or a salt thereof, wherein each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is H.
40 . The compound of claim 25 , or a salt thereof, wherein:
each R 2a and R 2b is independently H, unsubstituted C 1 -C 8 alkyl, halo or R 2a and R 2b are taken together to form a carbonyl moiety; and each R 3a and R 3b is independently H, unsubstituted C 1 -C 8 alkyl, halo.
41 . The compound of claim 25 , or a salt thereof, wherein each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is independently H, hydroxyl, unsubstituted C 1 -C 4 alkyl, is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a carbonyl moiety or is taken together with a geminal R 8(a-f) to form a methylene or a substituted methylene.
42 . The compound of claim 25 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy, or is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a cycloalkyl moiety or a carbonyl moiety.
43 . The compound of claim 25 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is taken together with a geminal R 8(a-f) to form a methylene or a substituted methylene, is taken together with a vicinal R 8(a-f) and the carbon atoms to which they are attached to form a substituted or unsubstituted C 3-8 cycloalkyl, substituted or unsubstituted C 3-8 cycloalkenyl or substituted or unsubstituted heterocyclyl moiety or is taken together with a vicinal R 8(a-f) to form a bond, provided that when an R 8(a-f) is taken together with a vicinal R 8 to form a bond, the geminal R 8(a-f) is other than hydroxyl.
44 . The compound of claim 25 , or a salt thereof, wherein each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is H.
45 . The compound of claim 25 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is other than H.
46 . The compound of claim 25 , or a salt thereof, wherein at least one of R 8c , R 8d , R 8e and R 8f , where present, is other than H.
47 . The compound of claim 25 , or a salt thereof, wherein at least one of R 8e and R 8f , where present, is other than H.
48 . The compound of claim 25 , or a salt thereof, wherein Q is a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl.
49 . The compound of claim 48 , or a salt thereof, wherein Q is a substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl.
50 . The compound of claim 48 , or a salt thereof, wherein Q is selected from the group consisting of:
wherein each R 9 is independently a halo, cyano, nitro, perhaloalkyl, perhaloalkoxy, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, acyl, acyloxy, carbonylalkoxy, thioalkyl, substituted or unsubstituted heterocyclyl, alkoxy, substituted or unsubstituted amino, acylamino, sulfonylamino, sulfonyl, carbonyl, aminoacyl or aminocarbonylamino.
51 . The compound of claim 25 , or a salt thereof, wherein Q is a substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or a unsubstituted heterocyclyl.
52 . The compound of claim 51 , or a salt thereof, wherein Q is selected from the group consisting of:
wherein each R 9 is independently a halo, cyano, nitro, perhaloalkyl, perhaloalkoxy, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, acyl, acyloxy, carbonylalkoxy, thioalkyl, alkoxy, substituted or unsubstituted amino, acylamino, sulfonylamino, sulfonyl, carbonyl, aminoacyl or aminocarbonylamino.
53 . The compound of claim 25 , or a salt thereof, wherein Q is unsubstituted amino, substituted amino, alkoxy, aminoacyl, acyloxy, carbonylalkoxy, aminocarbonylalkoxy, acylamino, carboxy, cyano or alkynyl.
54 . The compound of claim 53 , or a salt thereof, wherein Q is aminoacyl.
55 . The compound of claim 54 , or a salt thereof, wherein Q is aminoacyl of the formula —NR a C(O)R b where R a is H or alkyl and R b is alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic or substituted heterocyclic.
56 . The compound of claim 55 , or a salt thereof, wherein R a is H.
57 . The compound of claim 56 , or a salt thereof, wherein R b is unsubstituted or substituted heteroaryl.
58 . The compound of claim 25 , or a salt thereof, wherein:
R 1 is unsubstituted alkyl; each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is H; and each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is independently H, hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy, or is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a cycloalkyl moiety or a carbonyl moiety.
59 . The compound of claim 57 , or a salt thereof, wherein each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is H.
60 . The compound of claim 57 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is other than H.
61 . The compound of claim 58 , or a salt thereof, wherein at least one of R 8c , R 8d , R 8e and R 8f , where present, is other than H.
62 . The compound of claim 58 , or a salt thereof, wherein at least one of R 8e and R 8f , where present, is other than H.
63 . The compound of claim 58 , or a salt thereof, wherein Q is a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl.
64 . The compound of claim 63 , or a salt thereof, wherein Q is a substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl.
65 . The compound of claim 58 , or a salt thereof, wherein Q is unsubstituted amino, substituted amino, alkoxy, aminoacyl, acyloxy, carbonylalkoxy, aminocarbonylalkoxy, acylamino, carboxy, cyano or alkynyl.
66 . The compound of claim 65 , wherein Q is aminoacyl.
67 . The compound of claim 66 , or a salt thereof, wherein Q is aminoacyl of the formula —NR a C(O)R b where R a is H or alkyl and R b is alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic or substituted heterocyclic.
68 . The compound of claim 67 , or a salt thereof, wherein R a is H.
69 . The compound of claim 68 , or a salt thereof, wherein R b is unsubstituted or substituted heteroaryl.
70 . The compound of claim 57 , or a salt thereof, wherein each R 4 is independently H, halo, substituted or unsubstituted C 1 -C 8 alkyl, or perhaloalkyl.
71 . A pharmaceutical composition comprising a compound according to claim 25 or a salt thereof, and a pharmaceutically acceptable carrier.
72 . A method of treating a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder or a neuronal disorder in an individual comprising administering to an individual in need thereof an effective amount of compound according to claim 25 or a salt thereof.
73 . A kit comprising a compound according to claim 25 or a salt thereof, and instructions for use in the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder or a neuronal disorder.
74 . A pharmaceutical composition comprising a compound according to claim 58 or a salt thereof, and a pharmaceutically acceptable carrier.
75 . A method of treating a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder or a neuronal disorder in an individual comprising administering to an individual in need thereof an effective amount of compound according to claim 58 or a salt thereof.
76 . A kit comprising a compound according to claim 58 or a salt thereof, and instructions for use in the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder or a neuronal disorder.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.